State of the Art ReviewAtherosclerosis

Imaging and Nanomedicine in Inflammatory Atherosclerosis

Science Translational Medicine  04 Jun 2014:
Vol. 6, Issue 239, pp. 239sr1
DOI: 10.1126/scitranslmed.3005101

You are currently viewing the abstract.

View Full Text

Log in


Abstract

Bioengineering provides unique opportunities to better understand and manage atherosclerotic disease. The field is entering a new era that merges the latest biological insights into inflammatory disease processes with targeted imaging and nanomedicine. Preclinical cardiovascular molecular imaging allows the in vivo study of targeted nanotherapeutics specifically directed toward immune system components that drive atherosclerotic plaque development and complication. The first multicenter trials highlight the potential contribution of multimodality imaging to more efficient drug development. This review describes how the integration of engineering, nanotechnology, and cardiovascular immunology may yield precision diagnostics and efficient therapeutics for atherosclerosis and its ischemic complications.

View Full Text